跳至主要内容
临床试验/NCT02686918
NCT02686918Unknown不适用

Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse - TIPA

Institut de Cancérologie de la Loire0 个研究点目标入组 100 人开始时间: 2016年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
主要终点
Percentage of consultation requiring a medical advice between IPA and oncologist

研究概览

简要总结

The main of this study is to assess the feasibility of a patients follow-up visit receiving trastuzumab subcutaneous by Advanced Practice Nurse.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient care at the Cancer Institute Lucien Neuwirth
  • •Patient aged over 18 years
  • •Patient with breast cancer overexpressing HER2 adjuvant
  • •Patient having finished their chemotherapy treatment with IV followed the oncologist day hospital
  • •Patient under Trastzumab subcutaneously
  • •Patient affiliated or entitled to a social security scheme (mandatory requirement for all studies)

排除标准

  • •Refusal to participate, most patient protected under guardianship.
  • •Patient in inability to understand the course of the study
  • •Patient with documented history of cognitive or psychiatric disorders.
  • •Patients pregnant or lactating
  • •Patients under guardianship or curatorship

研究组 & 干预措施

consultation by Advanced Practice Nurse.

Experimental

During consultations, patients will be seen successively by Advanced Practice Nurse and referent oncologist.

干预措施: Advanced Practice Nurse consultation (Other)

结局指标

主要结局

Percentage of consultation requiring a medical advice between IPA and oncologist

时间窗: 1 year

Estimate the correlation between the IPA and the oncologist about whether or not a medical opinion during the consultation

次要结局

  • Physician satisfaction questionnaire(1 year)
  • Percentage of consultations delegated to the IPA(1 year)

研究者

发起方
Institut de Cancérologie de la Loire
申办方类型
Other
责任方
Sponsor

相似试验